Dr. Rodrigo González Barrios de la Parra
Investigator at Mexico’s Instituto Nacional de Cancerología (INCan) and group leader of the Chromatin Regulation and Genomics Laboratory (CromGenLab). His work connects chromatin regulation and cancer epigenetics with the search for biomarkers in testicular cancer through the TESTINCan platform.

Positions
- Group Leader, Chromatin Regulation and Genomics Laboratory, INCan
- Medical Sciences Investigator “D”, Instituto Nacional de Cancerología
- Mexican National System of Researchers (SNI), level II
- Professor, School of Sciences, UNAM
Training
- PhD in Biomedical Sciences, Institute for Biomedical Research, UNAM
- BSc in Biology, School of Sciences, UNAM
Networks and consortia
- Member of the Testicular Cancer Consortium (TECAC)
- Founding member of the Mexican Epigenomics Network
Research
Contact
rodrigop@ciencias.unam.mx · Instituto Nacional de Cancerología, Mexico City
Recent publications
- 2026
Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing
Cuevas-Estrada B, Ríos-Rodríguez JA, García-Pacheco JA, Wegman-Ostrosky T, Cervera A, Alcaraz N, Montalvo-Casimiro M, Barrón-Hernández A, Castro-Hernández C, Jiménez-Ríos MA, Sobrevilla-Moreno N, Arriaga-Canon C, Herrera LA, González-Barrios R*.
NAR Cancer · 8(2):zcag007 · 2026
DOI: 10.1093/narcan/zcag007PubMed 42017013PMC13092976
Related research: Line III · Molecular signatures in TGCT
- 2026
Metabolic profile and skeletal muscle as predictors of survival in testicular germ cell tumors
Barrón-Hernández A, Ríos-Rodríguez JA, García-Pacheco JA, Cuevas-Estrada B, De-la-Rosa S, Castro-Hernández C, Jiménez-Ríos MA, Sobrevilla-Moreno N, Santibáñez-Andrade M, González-Barrios R*.
The Oncologist · 31(5):oyag072 · 2026
DOI: 10.1093/oncolo/oyag072PMC13092131
Related research: TESTINCan · Body composition and metabolism
- 2025
Palmitic acid induces dynamic time-dependent alterations in HDACs, neuronal chromatin acetylation, and gene expression
Rueda-Díaz SS, Soto-Santarriaga IF, Torres-Arciga K, García-Cruz VM, González-Barrios R, Flores-León M, Arias C.
Neurochemical Research · 50(4):220 · 2025
DOI: 10.1007/s11064-025-04469-wPubMed 40586999
Related research: Line I · Epigenetic chromatin remodeling
- 2025
Retrotransposon expression is upregulated in adulthood and suppressed during regeneration of the limb in the axolotl (Ambystoma mexicanum)
Ruiz-Pérez S, Alcaraz N, Torres-Arciga K, Ocampo-Cervantes JA, Cervera A, Castro-Hernández C, Sámano-Salazar CG, Soto-Reyes E, González-Barrios R*.
Advanced Biology · e00502 · 2025
DOI: 10.1002/adbi.202400502PubMed 40443108
Related research: Collaboration · Axolotl regeneration
- 2025
Founder variants in the Mexican population: a systematic review
Harari-Arakindji S, Metta-Harari T, Espino-Gutiérrez I, Taja-Chayeb L, González-Barrios R, Zatarain-Barrón ZL, García-Ortiz JE, Wegman-Ostrosky T.
Archives of Medical Research · 56(5):103209 · 2025
DOI: 10.1016/j.arcmed.2025.103209PubMed 40233595
Related research: Genomics of the Mexican population
- 2024
Underlying mechanisms of the protective effects of lifestyle factors on age-related diseases
Alcaraz N, Salcedo-Tello P, González-Barrios R, Torres-Arciga K, Guzmán-Ramos K.
Archives of Medical Research · 55:103014 · 2024
Related research: Collaboration · Epigenetics, environment and aging
- 2024
Key proteins for regeneration in A. mexicanum: transcriptomic insights from aged and juvenile limbs
Del Moral-Morales A, Sámano C, Ocampo-Cervantes JA, Topf M, Baumbach J, Hernández J, Torres-Arciga K, González-Barrios R*, Soto-Reyes E*.
Scientifica · 2024:5460694 · 2024
DOI: 10.1155/2024/5460694PMC11581807
Related research: Collaboration · Axolotl regeneration
- 2024
A molecular characterization of the allelic expression of the BRCA1 founder Δ9–12 pathogenic variant and its potential clinical relevance in hereditary cancer
Domínguez-Ortiz J, Álvarez-Gómez RM, Montiel-Manríquez R, Cedro-Tanda A, Alcaraz N, Castro-Hernández C, Bautista-Hinojosa L, Contreras-Espinosa L, Torres-Maldonado L, Fragoso V, Sánchez Y, González-Barrios R, De la Fuente M, Mejía ML, Juárez-Figueroa U, Padua A, Sosa-León R, Nicasio-Arzeta S, Rodríguez A, Luna F, Cisneros-Soberanis F, Frías S, Arriaga-Canon C, Herrera-Montalvo LA.
International Journal of Molecular Sciences · 25(12):6773 · 2024
DOI: 10.3390/ijms25126773PMC11204022
Related research: Hereditary cancer genomics
Earlier publications
Original articles 22
- 2023
Understanding sociodemographic factors among Hispanics through a population-based study on testicular cancer in Mexico
Ríos-Rodríguez JA, Montalvo-Casimiro M, Álvarez-López DI, Reynoso-Noverón N, Cuevas-Estrada B, Mendoza-Pérez J, Jiménez-Ríos MA, Wegman-Ostrosky T, Salcedo-Tello P, Scavuzzo A, Castro-Hernández C, Herrera LA, González-Barrios R*.
Journal of Racial and Ethnic Health Disparities · 2023
- 2022
Deep DNA sequencing of MGMT, TP53 and AGT in Mexican astrocytoma patients identifies an excess of genetic variants in women and a predictive biomarker
Carlos-Escalante JA, Mejía-Pérez SI, Soto-Reyes E, Guerra-Calderas L, Cacho-Díaz B, Torres-Arciga K, Montalvo-Casimiro M, González-Barrios R, … Herrera LA, Corona T, Wegman-Ostrosky T.
Journal of Neuro-Oncology · 2022
- 2022
Genomic profile in a non-seminoma testicular germ-cell tumor cohort reveals a potential biomarker of sensitivity to platinum-based therapy
González-Barrios R, Alcaraz N, Montalvo-Casimiro M, Cervera A, Arriaga-Canon C, Munguía-Garza P, Hinojosa-Ugarte D, Sobrevilla-Moreno N, Torres-Arciga K, Mendoza-Pérez J, Díaz-Chávez J, Cortés-González CC, Castro-Hernández C, Martínez-Cedillo J, Scavuzzo A, Pérez-Montiel D, Jiménez-Ríos MA, Herrera LA.
Cancers (Basel) 14(9):2065 · 2022
- 2022
CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy
Salgado-Albarrán M, Späth J, González-Barrios R, Baumbach J, Soto-Reyes E.
NPJ Systems Biology and Applications 8(1):5 · 2022
- 2022
Large-scale topological disruption of chromosome territories 9 and 22 is associated with nonresponse to treatment in CML
Fabián-Morales E, Vallejo-Escamilla D, Gudiño A, Rodríguez A, González-Barrios R, … Frías S, Herrera LA.
International Journal of Cancer 150(9):1455–1470 · 2022
- 2022
Proteasome inhibition alters mitotic progression through the upregulation of centromeric α-satellite RNAs
Cáceres-Gutiérrez RE, Andonegui MA, Oliva-Rico DA, González-Barrios R, … Francastel C, Herrera LA.
FEBS Journal 289(7):1858–1875 · 2022
- 2021
Transcriptome analysis identifies GATA3-AS1 as a long noncoding RNA associated with resistance to neoadjuvant chemotherapy in locally advanced breast cancer patients
Contreras-Espinosa L, Alcaraz N, De La Rosa-Velázquez IA, … González-Barrios R, … Arriaga-Canon C, Herrera LA.
Journal of Molecular Diagnostics · 2021
- 2021
Transcriptional profiles reveal deregulation of lipid metabolism and inflammatory pathways in neurons exposed to palmitic acid
Flores-León M, Alcaraz N, Pérez-Domínguez M, Torres-Arciga K, Rebollar-Vega R, De la Rosa-Velázquez IA, Arriaga-Canon C, Herrera LA, Arias C*, González-Barrios R*.
Molecular Neurobiology · 2021
- 2021
Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection
Salgado-Albarrán M, Navarro-Delgado EI, Del Moral-Morales A, Alcaraz N, Baumbach J, González-Barrios R*, Soto-Reyes E*.
npj Systems Biology and Applications · 2021
- 2021
Saliva is a reliable and accessible source for the detection of SARS-CoV-2
Herrera LA, Hidalgo-Miranda A, Reynoso-Noverón N, Meneses-García A, Mendoza-Vargas A, … González-Barrios R, et al.
International Journal of Infectious Diseases · 2021
- 2020
Sex-dependent pronociceptive role of spinal α5-GABAA receptor and its epigenetic regulation in neuropathic rodents
Franco-Enzástiga Ú, García G, Murbartián J, González-Barrios R, … Price TJ, Granados-Soto V.
Journal of Neurochemistry · 2020
- 2020
Landscape of germline genetic variants in AGT, MGMT, and TP53 in Mexican adult patients with astrocytoma
Carlos-Escalante JA, Gómez-Flores-Ramos L, Bian X, Perdomo-Pantoja A, de Andrade KC, Mejía-Pérez SI, Cacho-Díaz B, González-Barrios R, et al.
Cellular and Molecular Neurobiology · 2020
- 2019
The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer
Salgado-Albarrán M, González-Barrios R, Guerra-Calderas L, Alcaraz N, Sánchez-Correa TE, … Herrera LA, Baumbach J, Soto-Reyes E.
Oncogenesis 8:41 · 2019
- 2019
Histamine modulates midbrain dopamine neuron differentiation through the regulation of epigenetic marks
Vargas-Romero F, González-Barrios R, Guerra-Calderas L, Escobedo-Ávila I, Cortés-Pérez D, López-Ornelas A, Rocha L, Soto-Reyes E, Velasco I.
Frontiers in Cellular Neuroscience 13:215 · 2019
- 2019
Palmitic acid-induced NAD+ depletion is associated with the reduced function of SIRT1 and increased expression of BACE1 in hippocampal neurons
Flores-León M, Pérez-Domínguez M, González-Barrios R, Arias C.
Neurochemical Research 44(7):1747–1754 · 2019
- 2018
CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines
Guerra-Calderas L*, González-Barrios R*, Patiño C, Alcaraz N, Salgado-Albarrán M, Cantú de León D, et al.
Oncotarget 9:17028–17042 · 2018
- 2016
MAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors
López-Saavedra A, Ramírez-Otero M, Díaz-Chávez J, Cáceres-Gutiérrez R, Justo-Garrido M, Andonegui MA, Mendoza J, Downie-Ruíz Á, Cortés-González C, Reynoso N, Castro C, Domínguez-Gómez G, Santibáñez-Andrade M, Fabián-Morales E, Pruefer F, Luna-Maldonado F, González-Barrios R, Herrera LA.
Cell Cycle · 2016
- 2016
Methylation of DAPK and THBS1 genes in esophageal gastric-type columnar metaplasia
Herrera-Goepfert R, Oñate-Ocaña LF, Mosqueda-Vargas JL, Herrera LA, Castro C, Mendoza J, González-Barrios R.
World Journal of Gastroenterology 22(18):4567–4575 · 2016
- 2014
Differential distribution of HP1 proteins after trichostatin A treatment influences chromosomal stability in HCT116 and WI-38 cells
González-Barrios R, Soto-Reyes E, Quiroz-Báez R, Fabián-Morales E, Díaz-Chávez J, del Castillo V, Mendoza J, López-Saavedra A, Castro C, Herrera LA.
Cell Division 9:6 · 2014
- 2013
Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours
Mendoza J, Martínez J, Hernández C, Pérez-Montiel D, Castro C, Fabián-Morales E, Santibañez M, González-Barrios R, Díaz-Chávez J, Andonegui MA, Reynoso N, Oñate LF, Jiménez MA, Núñez M, Dyer R, Herrera LA.
British Journal of Cancer 109(1):68–75 · 2013
- 2012
Satellite 2 demethylation induced by 5-azacytidine is associated with missegregation of chromosomes 1 and 16 in human somatic cells
Prada D, González-Barrios R, Sánchez L, Castro C, Fabián E, Herrera LA.
Mutation Research 729(1–2):100–105 · 2012
- 2012
Disruption of CTCF at the miR-125b1 locus in gynecological cancers
Soto-Reyes E, González-Barrios R, Prada D, Cisneros-Soberanis F, Herrera-Goepfert R, Pérez V, Cantú D, Castro C, Recillas-Targa F, Herrera LA.
BMC Cancer 12:40 · 2012
Review articles 9
- 2023
Breaking the mold: epigenetics and genomics approaches addressing novel treatments and chemoresponse in TGCT patients
Cuevas-Estrada B, Montalvo-Casimiro M, Munguía-Garza P, Ríos-Rodríguez JA, González-Barrios R*, Herrera LA.
International Journal of Molecular Sciences 24(9):7873 · 2023
- 2022
Histones and their chaperones: adaptive remodelers of an ever-changing chromatinic landscape
Torres-Arciga K, Flores-León M, Ruiz-Pérez S, Trujillo-Pineda M, González-Barrios R*, Herrera LA.
Frontiers in Genetics 13:1057846 · 2022
- 2022
The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches
Alarcón-Zendejas AP, Scavuzzo A, Jiménez-Ríos MA, … González-Barrios R, Jiménez-Trejo F, Arriaga-Canon C, Herrera LA.
Prostate Cancer and Prostatic Diseases · 2022
- 2021
Genomics and epigenomics of axolotl regeneration
Sámano C, González-Barrios R, Castro-Azpíroz M, Torres-García D, Ocampo-Cervantes JA, Otero-Negrete J, Soto-Reyes E.
International Journal of Developmental Biology · 2021
- 2020
Epidrug repurposing: discovering new faces of old acquaintances in cancer therapy
Montalvo-Casimiro M*, González-Barrios R*, Meraz-Rodríguez MA, Juárez-González VT, Arriaga-Canon C, Herrera LA.
Frontiers in Oncology 10:605386 · 2020
- 2020
The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics
Bautista-Sánchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Velázquez IA, González-Barrios R, … Herrera LA.
Molecular Therapy – Nucleic Acids 20:409–420 · 2020
- 2018
The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer
Arriaga-Canon C, De la Rosa I, González-Barrios R, Montiel-Manríquez R, Oliva-Rico D, Jiménez-Trejo F, Cortés-González C, Herrera LA.
Oncotarget · 2018
- 2014
The role of the histone demethylase KDM4A in cancer
Guerra-Calderas L, González-Barrios R, Herrera LA, Cantú de León D, Soto-Reyes E.
Cancer Genetics · 2014
- 2012
Assembling pieces of the centromere epigenetics puzzle
González-Barrios R, Soto-Reyes E, Herrera LA.
Epigenetics 7(1) · 2012
Book chapters 3
- 2021
Bioinformatics of transcription factor binding prediction
Navarro-Delgado EI, Salgado-Albarrán M, Torres-Arciga K, Alcaraz N, Soto-Reyes E, Herrera LA, González-Barrios R.
En: Forero DA (ed.), Bioinformatics and Human Genomics Research. CRC Press · 2021
- 2019
Epigenetic data and disease
González-Barrios R, Salgado-Albarrán M, Alcaraz N, Arriaga-Canon C, Guerra-Calderas L, Contreras-Espinosa L, Soto-Reyes E.
En: Analyzing Network Data in Biology and Medicine. Cambridge University Press · 2019
- 2017
Cáncer de ovario: una nueva visión integral
Soto-Reyes E, González-Barrios R, Cantú de León D.
En: Biología Molecular y Genómica del Cáncer. PyDESA, México · 2017